Thyroid Cancer Trial, Recruiting NCT07218315 Sponsor: M.D. Anderson Cancer Center Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT07218315
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be willing to give written consent to take part in the study voluntarily.
  • You must agree to follow all study steps, including attending all follow-up appointments.
  • You have a thyroid nodule that has been tested and placed in a category called "Bethesda VI," the nodule is no larger than 1.5 cm, and there is no known spread to other areas.
  • You have a thyroid nodule in a category called "Bethesda V" and your calcitonin levels (a specific blood marker) are normal.
  • An ultrasound scan of the nodule to be treated must show it is 1.5 cm or smaller, has not grown outside the thyroid, and there is no sign of spread to nearby areas.
  • Your blood count, blood clotting, and thyroid function tests must all come back as normal.
  • If you are a woman who could become pregnant, you must have a negative pregnancy test before the procedure begins.
  • Women who could become pregnant and men taking part must agree to use an approved form of birth control throughout the study (confirm with trial site for the full list of accepted methods).
  • Men must also agree to use contraception for at least 4 months after the study procedure is completed.

Who may not be able to join:

  • Your biopsy results suggest a more aggressive or high-grade form of cancer.
  • There is evidence that the cancer has spread to nearby lymph nodes or other parts of the body.
  • You have previously had radiation treatment to your neck area.
  • You are pregnant at the time of enrollment.
  • You have any other health condition or situation that the study doctor feels could put you at significant risk, affect the study results, or prevent you from fully participating (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Victoria E Banuchi, MPH, M.D. Anderson Cancer Center

Phone: 713-563-7600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 February 2026
Est. completion
31 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety and Adverse Events (AEs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov